Findings

What do systematic reviews say?

10 questions · 11 findings · 4 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 6 · 54.5%GRADE not reported 1 · 9.1%Very low 1 · 9.1%Low 2 · 18.2%Moderate 0 · 0%High 1 · 9.1%

Surgery vs Radiotherapy alone

Recurrence · Adults with oropharyngeal cancer

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatment 2023 · Cochrane All outcomes
Recurrence: not reported.
0 studies
No studies found

Surgery vs Radiotherapy alone

Locoregional recurrence · Adults with oropharyngeal cancer

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatment 2023 · Cochrane All outcomes
Locoregional recurrence: not reported.
0 studies
No studies found

Surgery plus radiotherapy vs Radiotherapy alone

Recurrence · Adults with oral cavity or oropharyngeal cancer

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatment 2023 · Cochrane All outcomes
Recurrence: not reported.
0 studies
No studies found

Surgery plus radiotherapy vs Chemotherapy (chemoradiotherapy)

Recurrence · Adults with oral cavity or oropharyngeal cancer

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatment 2023 · Cochrane All outcomes
oral cavity
Recurrence: not reported for the oral cancer subgroup (Iyer 2015).
0 studies
No studies found

Surgery vs Pharmacological therapy

Recurrence · adults with growth‐hormone secreting pituitary adenomas

The review found no eligible studies for this question.

1 finding from 1 review

Surgical and non‐surgical interventions for primary and salvage treatment of growth hormone‐secreting pituitary… 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Surgery vs preoperative pharmacological therapy and surgery

Recurrence · adults with growth‐hormone secreting pituitary adenomas

1 finding from 1 review

Surgical and non‐surgical interventions for primary and salvage treatment of growth hormone‐secreting pituitary… 2024 · Cochrane Headline outcomes only
no estimate extracted
1 study · 61 participants
GRADE not reported

Mohs micrographic surgery vs surgical excision

Recurrence · adults with basal cell carcinoma of the skin

Mohs micrographic surgery showed no clear difference in recurrence at 3 years compared with surgical excision (low certainty).

2 findings from 1 review

Interventions for basal cell carcinoma of the skin 2020 · Cochrane Headline outcomes only
RR 0.64 [0.16, 2.64]
1 study · 331 participants
Low
Interventions for basal cell carcinoma of the skin 2020 · Cochrane Headline outcomes only
RR 0.61 [0.18, 2.04]
1 study · 259 participants
Low

Surgery vs any Medical Therapy

NON ‐ Healing (persistence or recurrence) · people with anal fissures

Any Surgery leads to lower NON ‐ Healing (persistence or recurrence) compared with any Medical Therapy (high certainty).

1 finding from 1 review

Non surgical therapy for anal fissure 2012 · Cochrane Headline outcomes only
OR 0.11 [0.06, 0.23]
15 studies · 979 participants
High

Surgery plus radiotherapy vs Radiotherapy alone

Locoregional recurrence · Adults with oral cavity or oropharyngeal cancer

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatment 2023 · Cochrane All outcomes
Locoregional recurrence: not reported.
0 studies
No studies found

Surgery plus radiotherapy vs Chemotherapy (chemoradiotherapy)

Locoregional recurrence · Adults with oral cavity or oropharyngeal cancer

1 finding from 1 review

Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatment 2023 · Cochrane All outcomes
oral cavity
Locoregional recurrence: reported difference between groups not statistically significant (P=0.355), but no useable data; 32 participants (1 RCT, Iyer 2015).
1 study · 32 participants
Very low